Skip to main content

Table 4 The results of clinical, endoscopic and histopathological examinations conducted before and after treatment

From: The evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot study

 

Before treatment

After treatment

Group

Dog

Clinical signs

Endoscopic changes

Histopathological changes

Clinical signs

Endoscopic changes

Histopathological changes

1

A

+++

+++

++

+

++

+

B

++

++

+

–

+

+

C

+

+

+

–

–

–

D

+

+

+

–

–

–

E

++

++

++

–

+

+

2

A

+++

+++

+++

–

–

+

B

++

+

++

–

–

+

C

++

++

++

–

–

–

D

+

+

++

–

–

–

E

++

+

++

–

–

–

3

A

+++

+++

+++

++

++

+

B

++

++

++

+

+

++

C

++

++

++

+

+

–

D

+

+

++

–

–

+

E

+

++

+

–

+

–

4

A

++

++

++

+++

++

++

B

++

+

+

++

++

++

C

++

++

++

+++

++

+++

D

+

+

+

++

+

++

E

+

+

++

++

++

++

  1. - no changes (score of 3–5 points)
  2. + mild signs/changes (score of 3–5 points)
  3. ++ moderate signs/changes (score of 6–8 points)
  4. +++ severe signs/changes (score of 9 points)
  5. Group 1 - prednisone (Encorton)
  6. Group 2- meloxicam (Gromeloksin), followed by prednisone (Encorton)
  7. Group 3- meloxicam (Gromeloksin)
  8. Group 4- placebo (empty gelatin capsules)